Lioresal (Baclofen)

• Lioresal (baclofen) is employed to manage spasticity by modulating the central nervous system pathways that regulate muscle tone, offering therapeutic benefit in several neurologic conditions.
• Multiple sclerosis spasticity: reduces muscle stiffness, improves range of motion, and helps patients perform daily activities more comfortably.
• Spinal cord injury spasticity: decreases involuntary muscle contractions, facilitates physiotherapy, and supports functional recovery in affected limbs.
• Other central nervous system disorders causing hypertonia: alleviates excessive muscle tone, improves gait stability, and enhances overall quality of life.

• Baclofen acts as an agonist at GABA_B receptors located on pre‑synaptic terminals in the spinal cord. Activation of these metabotropic receptors inhibits calcium influx, reducing the release of excitatory neurotransmitters such as glutamate and aspartate. The resulting decrease in neuronal firing lowers the excitatory input to alpha‑motor neurons, leading to reduced muscle tone and attenuation of spasticity.

Baclofen may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Dizziness: a transient feeling of light‑headedness or imbalance that may affect standing or walking.
• Drowsiness: increased sleepiness or fatigue that can impair concentration and daily activities.
• Weakness: reduced muscle strength or a sensation of heaviness that may limit physical effort.

Serious or Rare Side Effects

• Severe hypotension: a marked drop in blood pressure that can cause fainting, dizziness, or shock.
• Respiratory depression: slowed or shallow breathing that may lead to inadequate oxygenation and requires urgent care.
• Allergic reactions: skin rash, itching, swelling, or anaphylaxis, which are medical emergencies.

When using Lioresal, clinicians should observe several precautionary measures to minimize risks and ensure optimal therapy.

• Monitor blood pressure: watch for hypotension especially after dose adjustments.
• Assess renal function: baclofen is renally excreted, dose may need modification in impairment.
• Avoid abrupt discontinuation: sudden stop can precipitate withdrawal symptoms such as seizures.
• Use caution with CNS depressants: concurrent opioids, benzodiazepines, or alcohol may enhance sedation.
• Evaluate seizure history: patients with epilepsy may have increased risk of seizures.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Baclofen can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid)

• Opioids: combined CNS depression may cause profound sedation or respiratory compromise.
• Benzodiazepines: additive sedative effects increase risk of excessive drowsiness.
• Alcohol: enhances central nervous system depression, leading to impaired coordination and breathing.

Moderate Interactions (Monitor Closely)

• Antihypertensive agents: baclofen may potentiate blood‑pressure‑lowering effects, requiring monitoring.
• CYP450 inhibitors (e.g., cimetidine): may increase baclofen plasma levels and side‑effect risk.
• Diuretics: can affect electrolyte balance and renal clearance, necessitating dose review.